Home › Astrocytoma › Florida › Miami
Astrocytoma clinical trials in Miami, FL
7 studies for Astrocytoma are looking for participants at sites in and around Miami (within about 30 miles). Open a study to see who can join and how to contact the study team.
Targeted Pediatric High-Grade Glioma Therapy
RecruitingObservational study
- University of Miami, Miami
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
RecruitingPhase 1
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
- UM Sylvester Comprehensive Cancer Center at Kendall, Miami
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
RecruitingPhase 3
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
- UM Sylvester Comprehensive Cancer Center at Kendall, Miami
Study of Olutasidenib and Temozolomide in HGG
RecruitingPhase 2
- University of Miami Hospital and Clinics, Miami
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
RecruitingPhase 3
- University of Miami Health, Miami
DB107-Retroviral Replicating Vector (RRV) Combined With DB107-Flucytosine (FC) in Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma
RecruitingPhase 2
- University of Miami Hospital, Miami
Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age
RecruitingPhase 1/2Healthy volunteers welcome
- Jackson Memorial Hospital, Miami
Astrocytoma trials in other cities
- Houston, TX14 studies
- Boston, MA13 studies
- Chicago, IL9 studies
- New York City, NY9 studies
- Philadelphia, PA7 studies
- Seattle, WA7 studies
- Columbus, OH6 studies
- Durham, NC6 studies
- Washington, DC6 studies
- Aurora, CO5 studies
- Cincinnati, OH5 studies
- San Francisco, CA5 studies
Other studies in Miami
- Breast Cancer42 studies
- Cancer (all types)36 studies
- Non-Small Cell Lung Cancer31 studies
- Prostate Cancer28 studies
- Obesity27 studies
- Acute Myeloid Leukemia24 studies
- Overweight23 studies
- Ovarian Cancer23 studies
- Metastatic Cancer23 studies
- Ulcerative Colitis22 studies
- Alzheimer's Disease21 studies
- Multiple Myeloma21 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.